Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the ten ratings firms that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $8.00.

HCAT has been the topic of several recent research reports. Wells Fargo & Company lowered their price objective on Health Catalyst from $13.00 to $10.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 21st. Canaccord Genuity Group decreased their price objective on shares of Health Catalyst from $10.00 to $9.00 and set a "buy" rating for the company in a research report on Thursday, May 8th. Stephens decreased their price objective on shares of Health Catalyst from $7.00 to $5.00 and set an "equal weight" rating for the company in a research report on Thursday, March 6th. Evercore ISI cut Health Catalyst from an "outperform" rating to an "inline" rating in a research report on Wednesday, April 9th. Finally, Piper Sandler cut their price objective on Health Catalyst from $12.00 to $8.00 and set an "overweight" rating for the company in a research report on Tuesday, February 11th.

Insider Buying and Selling

In other news, COO Daniel Lesueur sold 16,902 shares of the stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $4.52, for a total value of $76,397.04. Following the completion of the sale, the chief operating officer now directly owns 216,250 shares in the company, valued at $977,450. This represents a 7.25% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, General Counsel Benjamin Landry sold 13,827 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $4.55, for a total value of $62,912.85. Following the completion of the sale, the general counsel now owns 160,437 shares of the company's stock, valued at $729,988.35. This trade represents a 7.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 41,147 shares of company stock worth $182,284. 2.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Health Catalyst

Large investors have recently made changes to their positions in the stock. Quantbot Technologies LP purchased a new stake in shares of Health Catalyst in the fourth quarter valued at approximately $29,000. Group One Trading LLC lifted its stake in Health Catalyst by 107.6% during the 4th quarter. Group One Trading LLC now owns 4,360 shares of the company's stock worth $31,000 after acquiring an additional 2,260 shares in the last quarter. Focus Partners Wealth acquired a new position in Health Catalyst during the 1st quarter worth about $46,000. XTX Topco Ltd purchased a new stake in Health Catalyst during the 1st quarter worth approximately $54,000. Finally, Aquatic Capital Management LLC acquired a new position in Health Catalyst during the 4th quarter worth $63,000. 85.00% of the stock is currently owned by hedge funds and other institutional investors.

Health Catalyst Stock Performance

HCAT traded up $0.04 on Monday, reaching $3.94. 264,143 shares of the stock were exchanged, compared to its average volume of 597,429. Health Catalyst has a fifty-two week low of $3.56 and a fifty-two week high of $9.24. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.41 and a quick ratio of 1.41. The firm has a market capitalization of $274.23 million, a PE ratio of -2.92 and a beta of 1.56. The company's 50-day moving average price is $4.12 and its 200 day moving average price is $5.75.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.